1. Home
  2. CPIX vs NEPH Comparison

CPIX vs NEPH Comparison

Compare CPIX & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • NEPH
  • Stock Information
  • Founded
  • CPIX 1999
  • NEPH 1997
  • Country
  • CPIX United States
  • NEPH United States
  • Employees
  • CPIX N/A
  • NEPH N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • NEPH Medical/Dental Instruments
  • Sector
  • CPIX Health Care
  • NEPH Health Care
  • Exchange
  • CPIX Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • CPIX 46.2M
  • NEPH 45.3M
  • IPO Year
  • CPIX 2009
  • NEPH 2004
  • Fundamental
  • Price
  • CPIX $3.64
  • NEPH $5.36
  • Analyst Decision
  • CPIX
  • NEPH Strong Buy
  • Analyst Count
  • CPIX 0
  • NEPH 2
  • Target Price
  • CPIX N/A
  • NEPH $5.50
  • AVG Volume (30 Days)
  • CPIX 24.8K
  • NEPH 66.1K
  • Earning Date
  • CPIX 11-06-2025
  • NEPH 11-06-2025
  • Dividend Yield
  • CPIX N/A
  • NEPH N/A
  • EPS Growth
  • CPIX N/A
  • NEPH N/A
  • EPS
  • CPIX N/A
  • NEPH 0.12
  • Revenue
  • CPIX $42,071,813.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • CPIX N/A
  • NEPH $24.38
  • Revenue Next Year
  • CPIX N/A
  • NEPH $10.16
  • P/E Ratio
  • CPIX N/A
  • NEPH $47.49
  • Revenue Growth
  • CPIX 11.34
  • NEPH 21.16
  • 52 Week Low
  • CPIX $1.04
  • NEPH $1.36
  • 52 Week High
  • CPIX $7.25
  • NEPH $5.94
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 54.53
  • NEPH 76.83
  • Support Level
  • CPIX $3.08
  • NEPH $4.52
  • Resistance Level
  • CPIX $3.61
  • NEPH $5.97
  • Average True Range (ATR)
  • CPIX 0.21
  • NEPH 0.31
  • MACD
  • CPIX 0.04
  • NEPH 0.14
  • Stochastic Oscillator
  • CPIX 73.80
  • NEPH 91.64

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: